By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ImmunoGen, Inc. 

128 Sidney Street

Cambridge  Massachusetts  02139-4239  U.S.A.
Phone: 617-995-2500 Fax: 617-995-2510


SEARCH JOBS




Collaborations

GlaxoSmithKline (North Carolina) 

Raven Biotechnologies, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.

Medarex, Inc.  Partnership for the discovery and development of therapeutic MAbs for the treatment of ovarian cancer.





Company News
ImmunoGen (IMGN) Reports Fourth Quarter And Fiscal Year 2015 Financial Results 7/31/2015 8:00:34 AM
ImmunoGen (IMGN) Announces Conference Call To Discuss Its Fourth Quarter And Fiscal Year 2015 Financial Results 7/15/2015 10:36:47 AM
ImmunoGen (IMGN)’s IMGN529 For B-Cell Malignancies Demonstrates Synergistic Activity With Rituximab In Preclinical Models Of Non-Hodgkin Lymphoma 6/17/2015 10:23:41 AM
ImmunoGen (IMGN)’s IMGN529 For B-Cell Malignancies Demonstrates Synergistic Activity With Rituximab In Preclinical Models Of Non-Hodgkin Lymphoma 6/17/2015 10:08:06 AM
ASCO15: ImmunoGen (IMGN)'s Mirvetuximab Soravtansine (IMGN853) Demonstrates Notable Single Agent Activity For Patients With Platinum-Resistant Ovarian Cancer 6/1/2015 5:56:39 AM
ASCO15: Analyst Calls ImmunoGen (IMGN)'s Phase I Ovarian Cancer Data "Impressive" 6/1/2015 5:50:12 AM
Investors Wait With Bated Breath for ImmunoGen (IMGN)'s Ovarian Cancer Drug ASCO News 5/28/2015 5:41:58 AM
ImmunoGen (IMGN) Announces Clinical Data Presentations At Upcoming ASCO Annual Meeting 5/14/2015 12:20:00 PM
ImmunoGen (IMGN) Announces Webcast Of Presentations At Upcoming Investor Conferences 5/4/2015 11:27:15 AM
ImmunoGen (IMGN) Has Good News, Bad News as Sanofi (SAN.PA) SAAR3419 Deal Falls Apart and Ovarian Cancer Treatment Moves Forward 4/28/2015 6:50:17 AM
12345678910...
//-->